Annulled the expression of the oncogene by inserting a fluorescent reporter gene into the BCR/ABL coding sequence in order to select the edited hematopoietic cells of CML and decrease of over 80% in BCR/ABL expression levels [23]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.